Category: Research

Last week, our first lab tour of 2020 gave some of our supporters a chance to witness our funded research first-hand.

An affordable, point of care blood test to diagnose brain tumours was announced today by The University of Bristol.

On January 31, the UK formally left the European Union (EU). As a result, we have now entered into an 11-month transition period, as the future UK-EU relationship is negotiated.

In April, NHSX, the unit whose remit is to deliver the digital transformation of the health service, will begin running a new artificial intelligence (AI) Lab.

The phase 3 clinical trial aims to study oral eflornithine as a possible new treatment for patients with recurrent anaplastic astrocytoma.

This new role will establish and lead programmes in neuro-oncology and neuro-immunology, a step forward for our community.

Widely reported, the artificial intelligence diagnosis was faster than a pathologist, just…

Co-funded by us, Children with Cancer UK and Action Medical Research, the study from the University of Birmingham is the first of its kind.

New diagnostic techniques are driving real change in treatments for childhood brain tumours, a study reveals.

Reported in The Times this morning, thousands have benefited over the last ten years due to surgical improvements.

Reported at this week’s The National Cancer Research Institute (NCRI) conference, the innovative test could change the way brain tumours are diagnosed earlier.

Researchers have developed a blood test that could help identify people with a brain tumour, even if they have no clear-cut symptoms.

A study released this morning revealed that too few children are receiving targeted drugs for their cancers

Tocagen, an American gene-therapy company, announced the trial’s failure yesterday.

For a limited time the voting is open to decide the semifinalists in our Brain Race, with the Centre for Advancing Innovation. Which discoveries do you want to see go forward?

New findings out of the University of Sussex could be paving the way to a new test for glioblastoma (GBM) using only fluids, like blood or cerebrospinal fluid.

Researchers at The University of California, San Diego, have found that a drug called teriflunomide has the ability to boost the effectiveness of chemotherapy drugs to treat glioblastomas.

Dr Martina Finetti tells us about her background and her research into rare childhood brain tumours.

Researchers at St. Jude Children’s Hospital uncover the origins of medulloblastoma subgroup using single cell sequencing.

Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting highlight from the 2019 annual British Neuro-Oncology Society (BNOS) conference.

We have recently announced we will funding a study that looks at whether a therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour survivors.

With funding from The Brain Tumour Charity, researchers in Toronto, Canada are using the power of artificial intelligence (AI) to improve brain tumour diagnosis

We’re delighted to announce our £1.35m investment in a pioneering drive to help accelerate research into brain tumours at one of the UK’s leading universities.

Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference